Select Equity Group L.P. grew its holdings in Endava plc (NYSE:DAVA) by 121.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,512 shares of the company’s stock after buying an additional 4,113 shares during the quarter. Select Equity Group L.P.’s holdings in Endava were worth $636,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also bought and sold shares of the company. Meeder Asset Management Inc. acquired a new position in Endava during the first quarter worth $72,000. Captrust Financial Advisors raised its holdings in Endava by 154.1% during the fourth quarter. Captrust Financial Advisors now owns 1,837 shares of the company’s stock worth $141,000 after purchasing an additional 1,114 shares during the last quarter. Barclays PLC raised its holdings in Endava by 2,444.0% during the first quarter. Barclays PLC now owns 1,908 shares of the company’s stock worth $161,000 after purchasing an additional 1,833 shares during the last quarter. Cambridge Investment Research Advisors Inc. acquired a new position in Endava during the first quarter worth $202,000. Finally, Sowell Financial Services LLC acquired a new position in Endava during the first quarter worth about $207,000. 47.01% of the stock is owned by institutional investors and hedge funds.
A number of equities analysts have issued reports on DAVA shares. Zacks Investment Research cut shares of Endava from a “buy” rating to a “hold” rating in a research report on Tuesday. Citigroup boosted their price target on Endava from $110.00 to $137.00 and gave the stock a “buy” rating in a report on Wednesday, July 14th. Susquehanna Bancshares boosted their price target on Endava from $100.00 to $108.00 and gave the stock a “positive” rating in a report on Thursday, May 20th. Morgan Stanley boosted their price objective on shares of Endava from $93.00 to $102.00 and gave the company an “equal weight” rating in a research report on Thursday, May 20th. Finally, Susquehanna boosted their price objective on shares of Endava from $100.00 to $108.00 and gave the company a “positive” rating in a research report on Thursday, May 20th. Four equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Endava presently has a consensus rating of “Buy” and an average price target of $100.78.
Endava (NYSE:DAVA) last released its quarterly earnings data on Tuesday, May 18th. The company reported $34.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $33.72. The company had revenue of $112.30 million during the quarter, compared to analyst estimates of $111.21 million. Endava had a net margin of 8.40% and a return on equity of 13.26%. The business’s quarterly revenue was up 21.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.23 earnings per share. As a group, sell-side analysts expect that Endava plc will post 1.02 EPS for the current fiscal year.
Endava plc provides technology services for clients in the consumer products, healthcare, logistics, and retail verticals in Europe, Latin America, and North America. It offers technology and digital advisory services for financial services, healthcare, manufacturing, retail and consumer, business and support services, and TMT sectors; IT strategies; business analysis services in payments, financial services, asset and wealth management, insurance, telecommunications, and digital media areas; program management services; digital product strategy services; and architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.
Featured Story: Trading Strategy Examples and Plans
Want to see what other hedge funds are holding DAVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Endava plc (NYSE:DAVA).
Receive News & Ratings for Endava Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endava and related companies with MarketBeat.com's FREE daily email newsletter.